title: Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines.
abstract: Epidemiologic studies support the premise that Allium vegetables may lower the risk of cancers. The beneficial effects appear related to the organosulfur products generated upon processing of Allium. Leukemia cells from patients with acute myeloid leukemia (AML) display high proliferative capacity and have a reduced capacity of undergoing apoptosis and maturation. Whether the sulfur-containing molecules thiosulfinates (TS), diallyl TS (All(2)TS), dipropyl TS (Pr(2)TS) and dimethyl TS (Me(2)TS), are able to exert chemopreventative activity against AML is presently unknown. The present study was an evaluation of proliferation, cytotoxicity, differentiation and secretion of AML cell lines (U937, NB4, HL-60, MonoMac-6) in response to treatment with these TS and their related sulfides (diallylsulfide, diallyl disulfide, dipropyl disulfide, dimethyl disulfide). As assessed by flow cytometry, ELISA, gelatin zymogaphy and RT-PCR, we showed that Pr(2)TS and Me(2)TS, but not All(2)TS and sulfides, 1) inhibited cell proliferation in dose- and time-dependent manner and this process was neither due to cytotoxicity nor apoptosis, 2) induced macrophage maturation, and 3) inhibited the levels of secreted MMP-9 (protein and activity) and TNF-alpha protein, without altering mRNA levels. By establishing for the first time that Pr(2)TS and Me(2)TS affect proliferation, differentiation and secretion of leukemic cell lines, this study provides the opportunity to explore the potential efficiency of these molecules in AML.
authors.affiliation: UMR 7131 UPMC Paris Universitas/ CNRS, Groupe Hospitalier Broussais-HEGP, Paris, France.
authors.forename: Faten
authors.initials: F
authors.lastname: Merhi
authors.forename: Jacques
authors.initials: J
authors.lastname: Auger
authors.forename: Francine
authors.initials: F
authors.lastname: Rendu
authors.forename: Brigitte
authors.initials: B
authors.lastname: Bauvois
references.citation: Biochim Biophys Acta. 2000 Mar 27;1470(2):M55-62
references.pmid: 10722927
references.citation: Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):33-52
references.pmid: 16529548
references.citation: Blood Rev. 2006 Mar;20(2):71-82
references.pmid: 16185796
references.citation: Biologics. 2007 Dec;1(4):415-24
references.pmid: 19707311
references.citation: Carcinogenesis. 2006 Mar;27(3):533-40
references.pmid: 16169930
references.citation: J Immunol. 1990 Feb 15;144(4):1311-6
references.pmid: 2105994
references.citation: J Cell Sci. 1993 Apr;104 ( Pt 4):991-9
references.pmid: 8314909
references.citation: J Chromatogr A. 2006 Apr 21;1112(1-2):3-22
references.pmid: 16388813
references.citation: Cancer Res. 2001 Jan 1;61(1):2-7
references.pmid: 11196162
references.citation: Biochem Pharmacol. 2000 Nov 15;60(10):1475-83
references.pmid: 11020449
references.citation: J Chromatogr A. 2003 Mar 28;991(1):69-75
references.pmid: 12703902
references.citation: Acta Haematol. 2004;111(1-2):107-23
references.pmid: 14646349
references.citation: Leuk Res. 1998 Jun;22(6):537-47
references.pmid: 9678720
references.citation: Blood. 1990 Feb 1;75(3):626-32
references.pmid: 2153423
references.citation: Stem Cells Dev. 2004 Oct;13(5):484-95
references.pmid: 15588506
references.citation: Cancer Res. 2003 Oct 15;63(20):6825-37
references.pmid: 14583480
references.citation: Platelets. 2007 Nov;18(7):481-90
references.pmid: 17852771
references.citation: Blood. 2003 Jun 15;101(12):4667-79
references.pmid: 12623839
references.citation: Cancer Metastasis Rev. 2006 Mar;25(1):9-34
references.pmid: 16680569
references.citation: J Nutr. 2006 Mar;136(3 Suppl):716S-725S
references.pmid: 16484550
references.citation: J Immunol Methods. 2002 Jan 1;259(1-2):55-64
references.pmid: 11730841
references.citation: J Nutr. 2006 Mar;136(3 Suppl):827S-831S
references.pmid: 16484574
references.citation: Carcinogenesis. 1996 Apr;17(4):669-73
references.pmid: 8625476
references.citation: Curr Oncol Rep. 2007 Sep;9(5):337-44
references.pmid: 17706161
references.citation: Cell Biol Toxicol. 2004 Jul;20(4):253-60
references.pmid: 15499972
references.citation: Life Sci. 2002 Jun 14;71(4):411-9
references.pmid: 12044841
references.citation: Cell Death Differ. 2006 May;13(5):748-58
references.pmid: 16498458
references.citation: J Nutr. 2001 Mar;131(3s):1058S-60S
references.pmid: 11238816
references.citation: Cancer. 2008 Feb 1;112(3):572-80
references.pmid: 18085638
references.citation: Leukemia. 2004 Feb;18(2):227-32
references.pmid: 14671638
references.citation: J Cell Biochem Suppl. 1997;27:106-12
references.pmid: 9591200
references.citation: J Nutr. 2006 Mar;136(3 Suppl):810S-812S
references.pmid: 16484570
references.citation: Eur J Immunol. 1999 Sep;29(9):3009-16
references.pmid: 10508275
references.citation: Leukemia. 2002 May;16(5):791-8
references.pmid: 11986939
references.citation: Crit Rev Food Sci Nutr. 2004;44(6):479-88
references.pmid: 15615431
references.citation: Blood. 1999 Sep 15;94(6):1971-8
references.pmid: 10477726
references.citation: Drug Metabol Drug Interact. 2000;17(1-4):51-79
references.pmid: 11201304
references.citation: Acta Haematol. 2001;106(4):190-207
references.pmid: 11815717
references.citation: Leukemia. 2007 Aug;21(8):1605
references.pmid: 17637714
references.citation: Blood. 1991 Mar 1;77(5):1080-6
references.pmid: 1995093
references.citation: Lancet Neurol. 2003 Dec;2(12):747-56
references.pmid: 14636780
references.citation: Biochim Biophys Acta. 1996 Jan 17;1315(1):15-20
references.pmid: 8611641
references.citation: J Clin Invest. 2001 Sep;108(6):851-9
references.pmid: 11560954
references.citation: Nat Rev Immunol. 2004 Aug;4(8):617-29
references.pmid: 15286728
references.citation: Crit Rev Oncol Hematol. 2004 May;50(2):87-100
references.pmid: 15157658
references.citation: Biologics. 2008 Mar;2(1):143-9
references.pmid: 19707437
references.citation: J Hematother Stem Cell Res. 2002 Feb;11(1):33-47
references.pmid: 11847002
references.citation: J Exp Med. 1995 Nov 1;182(5):1545-56
references.pmid: 7595224
references.citation: Leuk Res. 1991;15(6):409-18
references.pmid: 1861527
references.citation: Biochem Pharmacol. 2002 Jan 1;63(1):41-7
references.pmid: 11754872
references.citation: Leukemia. 2002 Oct;16(10):2062-71
references.pmid: 12357358
references.citation: Mol Cancer Ther. 2005 Sep;4(9):1388-98
references.pmid: 16170031
references.citation: J Biol Chem. 2005 Dec 16;280(50):41487-93
references.pmid: 16219763
references.citation: Blood. 2001 Jun 15;97(12):3919-24
references.pmid: 11389035
references.citation: J Biol Chem. 2004 Apr 23;279(17):17772-84
references.pmid: 14754893
references.citation: Blood. 1994 Jul 1;84(1):294-302
references.pmid: 7517212
references.citation: Oncologist. 2007;12 Suppl 2:14-21
references.pmid: 18039635
references.citation: Mutat Res. 2004 Nov 2;555(1-2):121-31
references.pmid: 15476856
references.citation: Arch Intern Med. 2001 Mar 26;161(6):813-24
references.pmid: 11268223
references.citation: Leuk Res. 2008 Feb;32(2):315-22
references.pmid: 17561254
references.citation: Thromb Haemost. 2001 Nov;86(5):1284-91
references.pmid: 11816719
references.citation: Blood. 1997 Mar 15;89(6):1870-5
references.pmid: 9058706
references.citation: Int J Cancer. 2000 Jun 15;86(6):768-76
references.pmid: 10842189
references.citation: Haematologica. 2007 Sep;92(9):1224-9
references.pmid: 17666366
references.citation: Blood. 1987 Nov;70(5):1233-44
references.pmid: 3311197
references.citation: J Biol Chem. 2001 Nov 30;276(48):45491-6
references.pmid: 11585813
references.citation: Leukemia. 1999 Jun;13(6):835-42
references.pmid: 10360369
references.citation: J Nutr. 2003 Jul;133(7):2171-5
references.pmid: 12840173